Targeted Therapy Combined with Immune Checkpoint Therapy: Is This the Wave of the Future?
Jean H. Hoffman-Censits, MD explores combining targeted therapy with immune checkpoint therapy to treat bladder cancer.
Read More
Latest Videos
High Risk and Advanced Upper Tract Urothelial Carcinoma – Still a Role for Surgery
Jennifer A. Linehan, MD explores the treatment of advanced upper tract urothelial carcinoma (UTUC), focusing on therapeutic strategies.
Read More
Utilizing Molecular Characterization of Invasive Bladder Cancer: What It Means Now and In the Future
Jennifer A. Linehan, MD, discusses molecular characterization in invasive bladder cancer, molecular profiling, FGFR3 mutations and FGFR inhibitors.
Read More
Immune Checkpoint Inhibitors: Combination Therapy
Jean H. Hoffman-Censits, MD, focuses on studies of PD-1 and PD-L1 inhibitors combined with other agents in bladder cancer treatment.
Read More
Immune Checkpoint Inhibitors: Managing Immune-related Side Effects
Guru P. Sonpavde, MD, explains immune checkpoint inhibitors and their role in activating the immune system to fight cancer.
Read More